Patent applications published 5 May 2010
Selected patent applications from the weekly European Patents Bulletin
- Nitrated-fatty acid modulation of type II diabetes
University of Pittsburgh - Of The Commonwealth System of Education 2180787*
- Anti-inflammatory compounds and uses thereof
Rigas, Basil 2180788*
- Micell encapsulation of therapeutic agents
Kwon, Glen; Forrest, M Laird; Davies, Neal 2180880*
- Vesicles comprising a transmembrane transport trigger system
BASF SE 2180881*
- Solid matrix pharmaceutical preparation
Otsuka Pharmaceutical 2180882*
- Pharmaceutical compsn containing dihydropyridine calcium channel antagonist and method for the preparation thereof
Pharmathen 2180883*
- Central administration of stable formulations of therapeutic agents for CNS conditions
The Regents of the University of Colorado 2180884*
- Pharmaceutical product comprising yeast
LTS Lohmann Therapie-Systeme 2180885*
- Modified release solid or semi-solid dosage forms
McNeil-PPC 2180886*
- Pharmaceutical preparations containing highly volatile silicones
Egis Gyogyszergyar Nyilvánosan Múködó Részvénytársaság 2180887*
- Novel combinations of neramexane for the treatment of neurodegenerative disorders
Merz Pharma 2180888*
- Extracts with liver-X-receptor modulators, compounds and their use especially in weight control
InterMed Discovery 2180889*
- Methods of inhibiting or suppressing cellular proliferation
Medtronic 2180890*
- Combination preparation comprising inhibitor of HMG-CoA reductase and aspirin and method for manufacturing the same
Hanall Pharmaceutical 2180891*
- Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as COPD or asthma
Boehringer Ingelheim International 2180892*
- Pharmaceutical compsns and methods for the treatment of cancer
Urifer 2180893*
- Methods of activating IRS-1 and AKT
Melior Pharmaceutical 2180894*
- Methods for improving healing of an oral lesion using a glycerophosphate salt
Prelief 2180895*
- Compsn for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or gro-alpha, comprising UCB-MSCS
Medipost 2180896*
- Peptide tyrosinase inhibitors and uses thereof
The Board of Trustees of the Leland Stanford Junior University 2180897*
- The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
Merz Pharma 2180898*
- Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases
Ramot at Tel Aviv University 2180899*
- antibacterial combination therapy
E-Therapeutics 2180900*
- Conjugate purification
Novartis 2180901*
- Imaging medium comprising hyperpolarised 13C-acetate and use thereof
GE Healthcare 2180902*
- Preparation of 2-(1,3-dimethylbutyl)aniline and other branched alkyl-substituted anilines
Albemarle 2181088*
- Process for preparing pentanoic diacid derivatives
Ratiopharm 2181089*
- Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
Addex Pharmaceuticals 2181091*
- 1,3-dihydroisoindole derivatives
Merck Patent 2181092*
- Immobilisation of dyes and antimicrobial agents on a medical device
Baxter International; Baxter Healthcare 2181093*
- Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
Respiratorius 2181095*
- Crystalline forms of erlotinib HCl and formulations thereof
Plus Chemicals 2181099*
- Tubulysin D analogues
Helmholtz-Zentrum für Infektionsforschung 2181101*
- Process for controlled crystal size in 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
Schering 2181102*
- System for controlling the reactivity of boronic acids
The Board of Trustees of the University of Illinois 2181103*
- Zearalenone macrolide derivatives and uses of the same
Eisai R&D Management 2181104*
- N5-(2-ethoxyethyl)-N3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
Novartis 2181105*
- Process for preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate
Ranbaxy Laboratories 2181106*
- Process for preparing 2-sulfinyl-1H-benzimidazoles
Krka, Torvana Zdravil 2181107*
- 3-heterocyclydene-indolinone derivatives as inhibitors of specific cell cycle kinases
Boehringer Ingelheim International 2181108*
- Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
Hetero Drugs 2181109*
- Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
ADDEX Pharma 2181110*
- Thiadaizinone derivatives
Merck Patent 2181111*
- Traizolopyridine compounds and their use as ASK inhibitors
Merck Serono 2181112*
- Polycarboxylate phthaleins used as fluores-cent dyes and method for preparation thereof
Laboratoires Synth-Innove 2181113*
- New drugs with anticholestatic activity
Segix Italia 2181114*
- Process for treatment of kappa carrageenan
CP Kelco 2181115*
- Macrolides solid-state forms
Intervet International; Microbial Chemical Research Foundation 2181117*
- Process for the production of pramlintide
Lonza 2181118*
- Allergens fro Aspergillus versicolor, and a method of detecting a mould allergy caused by interior rooms
Helmholtz-Zentrum für Umweltforschung 2181120*
- Chimeric antigens
ID Biomedical Corp 2181121*
- Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, compsn, prevention and treatment methods for rotavirus infections
Alternative Gene Expression; Instituto Nacional de Tecnología Agropecuaria (INTA) 2181122*
- Method for the production of protective colloid-stabilised polymer products and device for carrying out the method
Wacker Chemie 2181124*
- Process for producing high purity exo-alkenylnorbornene
Promerus 2181125*